EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

All-trans retinoic acid downregulates HBx levels via E6-associated protein-mediated proteasomal degradation to suppress hepatitis B virus replication

Jiwoo Han, Kyung Lib Jang iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0305350 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Jiwoo Han und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrated Biological Science, The Graduate School, Pusan National University, Busan, Republic of Korea. Hauptthemen laut MEDLINE: Viral Regulatory and Accessory Proteins, Trans-Activators, Proteasome Endopeptidase Complex, Virus Replication. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

All- trans retinoic acid (ATRA), recognized as the principal and most biologically potent metabolite of vitamin A, has been identified for its inhibitory effects on hepatitis B virus (HBV) replication. Nevertheless, the underlying mechanism remains elusive. The present study reveals that ATRA induces E6-associated protein (E6AP)-mediated proteasomal degradation of HBx to suppress HBV replication in human hepatoma cells in a p53-dependent pathway. For this effect, ATRA induced promoter hypomethylation of E6AP in the presence of HBx, which resulted in the upregulation of E6AP levels in HepG2 but not in Hep3B cells, emphasizing the p53-dependent nature of this effect. As a consequence, ATRA augmented the interaction between E6AP and HBx, resulting in substantial ubiquitination of HBx and consequent reduction in HBx protein levels in both the HBx overexpression system and the in vitro HBV replication model. Additionally, the knockdown of E6AP under ATRA treatment reduced the interaction between HBx and E6AP and decreased the ubiquitin-dependent proteasomal degradation of HBx, which prompted a recovery of HBV replication in the presence of ATRA, as confirmed by increased levels of intracellular HBV proteins and secreted HBV levels. This study not only contributes to the understanding of the complex interactions between ATRA, p53, E6AP, and HBx but also provides an academic basis for the clinical employment of ATRA in the treatment of HBV infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Viral Regulatory and Accessory ProteinsTrans-ActivatorsProteasome Endopeptidase ComplexVirus ReplicationHepatitis B virusTretinoinTumor Suppressor Protein p53Ubiquitin-Protein LigasesHumansHep G2 CellsDown-RegulationUbiquitinationProteolysisPromoter Regions, GeneticDNA MethylationCell Line, Tumor

Substanzen

hepatitis B virus X proteinViral Regulatory and Accessory ProteinsTrans-ActivatorsProteasome Endopeptidase ComplexTretinoinTumor Suppressor Protein p53UBE3A protein, humanUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • Department of Integrated Biological Science, The Graduate School, Pusan National University, Busan, Republic of Korea.
  • Department of Microbiology, College of Natural Science, Pusan National University, Busan, Republic of Korea.
  • Microbiological Resource Research Institute, Pusan National University, Busan, Republic of Korea.

ORCID-Profile: Kyung Lib Jang

Förderung

  • National Research Foundation

Zitieren

APA

Han, J., & Jang, K. L. (2024). All-trans retinoic acid downregulates HBx levels via E6-associated protein-mediated proteasomal degradation to suppress hepatitis B virus replication. PLOS ONE. https://doi.org/10.1371/journal.pone.0305350

Vancouver

Han J, Jang KL. All-trans retinoic acid downregulates HBx levels via E6-associated protein-mediated proteasomal degradation to suppress hepatitis B virus replication. PLOS ONE. 2024. doi:10.1371/journal.pone.0305350

BibTeX
@article{Han2024,
  author = {Han, Jiwoo and Jang, Kyung Lib},
  title = {All-trans retinoic acid downregulates HBx levels via E6-associated protein-mediated proteasomal degradation to suppress hepatitis B virus replication},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0305350}
}
Kostenlos starten →